KRAS and central nervous system cancer: RPTOR amplification was found to be significantly associated with young adult BRCA (FDR = 0.020), while amplifications of KDM5A, CCND2, KRAS, and ARRDC1 were each suggestively associated with young adult gliomas (FDR ≤ 0.148).